NewsRoom Articles - Page 180 of 225

MondayMar 29, 2021 2:28 pm

Study Finds Cancer Survivors Have Higher Risk of Developing Heart Disease

A study conducted recently discovered that nearly 35% of Americans who have a history with cancer have a higher chance of contracting cardiovascular ailments in the next 10 years, as compared to roughly 23% of Americans who do not have cancer. Researchers from The Ohio State University discovered that the average approximated 10-year risk for an individual who survived cancer was nearly 8%, in comparison with individuals who did not have a cancer history, which was found to be 5%. This was based off of a risk calculator that approximates an individual's 10-year risk of developing stroke or heart disease.…

MondayMar 29, 2021 12:29 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) New Investor Presentation Shows Value-Added Milestones for Berubicin in 2021

GBM is diagnosed in more than 13,000 people each year in the US, with only a 12–18-month life expectancy Potentially pivotal Phase 2 trial of Berubicin is scheduled to commence around the end of Q1 2021 The company is continuing its pre-clinical work on WP1244 during 2021 and 2022 CNS Pharmaceuticals participated in two virtual conferences during March, spreading awareness about Berubicin and the GBM indicator CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in developing novel treatments for primary and metastatic cancers of the brain and central nervous system, recently announced multiple value-driving milestones for its lead drug candidate…

MondayMar 29, 2021 11:29 am

Predictive Oncology’s (NASDAQ: POAI) Helomics Exec Talks AI, Big Data and Biology During Podcast Appearance

Convergence of AI, big data and biology allows Helomics to test drugs on living tumor tissue rather than artificial systems Helomics model evaluates multiple measurements in powerful multi-omics approach to cancer research Knowledge encapsulated by Helomics AI is “gold dust,” says chief innovation officer Data, AI and biology come together at Helomics in a way that promises exciting things for the future, according to Mark Collins, PhD and chief technical officer at the company, which is a subsidiary of Predictive Oncology (NASDAQ: POAI) (https://ibn.fm/ms1hL). Collins was a guest speaker on a DojoLIVE! podcast titled “Can We Cure Cancer with Artificial Intelligence?” where…

FridayMar 26, 2021 1:00 pm

High Bladder Cancer Treatment Cost Finds Help with Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Technology

Bladder cancer is the 6th most prevalent cancer in the United States and a problem worldwide Bladder cancer is more common in men than women at a 4:1 ratio Bladder cancer treatment has the highest cost per patient over the course of a lifetime because of its greater than 50% recurrence rate Surgeons, including urologists at the University of Washington, have adopted a solution that uses blue light and a contrast agent to better visualize bladder tumors and has been shown to be more successful and reduce costs Imagin Medical has taken this solution one step further by developing the…

FridayMar 26, 2021 1:00 pm

Researchers Have Found New Way to Hinder Excessive Inflammation

Researchers from the Royal College of Surgeons in Ireland have found another way to halt excessive inflammation. The method works by regulating a particular type of white blood cells that are crucial for the immune system in the human body. The researchers’ findings could potentially protect an individual’s body from the unhampered damage that is brought about by inflammatory ailments. The study, conducted by researchers at the University of Medicine and Health Sciences, Royal College of Surgeons in Ireland (“RCSI”), was reported in “Nature Communications” journal. The researchers explained that when the immune cells in an individual’s body known as…

ThursdayMar 25, 2021 3:30 pm

Vanderbilt University Acquires Funds to Study Factors That Affect Coronavirus Severity

Vanderbilt University Medical Center (“VUMC”) was recently awarded a $3.7 million, two-year contract by the United States Centers for Disease Control (“CDC”), to discover the bacterial and genetic factors that may grow the risk for critical illness and death from the coronavirus. The investigation conducted by the center will find out how the severity of the coronavirus may be influenced by respiratory microbiome, which is the bacteria that is found in the airways of a patient, as well as the genetic makeup of a patient. Researchers from VUMC stated in a report, which was published in February, that the virus…

WednesdayMar 24, 2021 12:15 pm

Study Finds Head Injuries Could Make Cognitive Decline Worse as Individuals Age

A study led by researchers from University College London has found that individuals who suffered head injuries when they were aged 50-something or below attained below-average scores on cognitive tests administered when they were age 70. The study’s findings, which were reported in the “Annals of Clinical and Translational Neurology,” found that while head injuries were not found to contribute to Alzheimer’s disease brain damage characteristics, they did make individuals more susceptible to symptoms of dementia. Dr. Sarah-Naomi James, the lead author of the study, explained that the researchers found irrefutable proof that head injuries in mid or early life…

TuesdayMar 23, 2021 2:30 pm

Study Finds Link Between Quality Sleep and Recovery from Traumatic Brain Injuries

New research conducted that focuses on military veterans has found that good sleep plays an important role in helping heal traumatic brain injuries. The study utilized a novel technique that was developed at the Oregon Health and Science University. Researchers assessed the expansion of perivascular spaces around the brain’s blood vessels using MRIs, reporting that these spaces enlarge as an individual continues ageing and are usually linked to the onset of dementia. The researchers found that of the veterans who participated in the research, those who didn’t sleep well had more post-concussive symptoms and indications of enlarged spaces. Juan Piantino,…

TuesdayMar 23, 2021 2:18 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Reports Manufacturing Progress for Innovative Bladder Cancer Imaging System

Imagin Medical believes the i/Blue System can revolutionize the current standard of care for bladder cancer patients by improving cancer visualization for removal, and potentially lowering recurrence rates Imagin Medical is leveraging the significant expertise in optics, electronics, software, and mechanical design of FDA-registered contract manufacturer, Lighthouse Imaging, to implement the final stage of the i/Blue(TM) Imaging System Lighthouse’s manufacturing program remains on track for product commercialization in 2022 Surgical imaging company Imagin Medical (CSE: IME) (OTCQB: IMEXF) is continuing progress with the commercial-stage manufacturing of its patented i/Blue Imaging System, an innovative technology that the company believes will revolutionize…

MondayMar 22, 2021 10:00 am

Study Suggests That Coronavirus Doesn’t Affect the Heart

A new study that was conducted to get to the bottom of whether the coronavirus causes heart issues where there are none, or whether individuals who already have heart problems are more prone to the virus, found that individuals with pre-existing heart issues appeared to have a higher risk of contracting the coronavirus. Zahra Raisi-Estabragh, the lead researcher of the study, explained that the team found that poorer heart function and structure was associated with an increased risk of getting the coronavirus. This, she said, was important because other studies had proposed that the coronavirus may lead to structural damage…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Study Finds Cancer Survivors Have Higher Risk of Developing Heart Disease

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) New Investor Presentation Shows Value-Added Milestones for Berubicin in 2021

Predictive Oncology’s (NASDAQ: POAI) Helomics Exec Talks AI, Big Data and Biology During Podcast Appearance

High Bladder Cancer Treatment Cost Finds Help with Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Technology

Researchers Have Found New Way to Hinder Excessive Inflammation

Vanderbilt University Acquires Funds to Study Factors That Affect Coronavirus Severity

Study Finds Head Injuries Could Make Cognitive Decline Worse as Individuals Age

Study Finds Link Between Quality Sleep and Recovery from Traumatic Brain Injuries

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Reports Manufacturing Progress for Innovative Bladder Cancer Imaging System

Study Suggests That Coronavirus Doesn’t Affect the Heart

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search